))
From The Heart - (SGLT2 inhibitors) Ep#3: From diabetes to heart failure!
Manage episode 337666494 series 3322188
İçerik RAS LSS Consulting tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan RAS LSS Consulting veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Today’s podcast is the third in the series of five episodes of “From The Heart - Tying the threads through the evolving body of evidence in HF “. Today's episode is focused on a new class of drugs in heart failure - The Sodium Glucose Like Transporter 2 inhibitors or as they are more commonly known as SGLT2is
For those who have just tuned in to our podcast series for the first time, please do listen into our first episode where we discussed about the basics of heart failure and a brief historical view of heart failure therapies (Link https://www.buzzsprout.com/1947788/10351733-from-the-heart-ep-1-introduction-to-heart-failure-and-a-brief-overview-of-evolving-hf-treatments.mp3?download=true)
The second episode discussed about Entresto, its mechanism of action and clinical evidence in heart failure. (Link https://www.buzzsprout.com/1947788/10498068-from-the-heart-ep-2-entresto-the-first-arni-approved-for-heart-failure.mp3?download=true)
7 bölüm
Paylaş
